News1 min read
Sickle Cell Disease FAQ: Subtypes, Current Therapies, and Access Challenges
About this article
- Published
- Last updated
- Further reading
- Read More(opens in a new tab)

Learn what sickle cell disease is, who it affects most, today’s treatment options, and how cost and inequities limit access.
Sickle cell disease (SCD) is a complex inherited blood disorder that disproportionately affects Black and African American communities in the US and millions of others worldwide.
This FAQ explores the major subtypes of SCD, current FDA-approved therapies, and emerging treatment strategies. Experts also highlight how cost, provider awareness, and systemic inequities continue to shape access to care.